[Federal Register Volume 77, Number 233 (Tuesday, December 4, 2012)]
[Rules and Regulations]
[Page 71702]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-28784]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

42 CFR Part 73

RIN 0920-AA34


Possession, Use, and Transfer of Select Agents and Toxins; 
Biennial Review

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services is correcting a 
final rule that appeared in the Federal Register on October 5, 2012 (77 
FR 61084). The document updated the list of HHS and overlap biological 
agents and toxins and designated certain select agents and toxins as 
Tier 1 agents.

DATES: Effective Date: Effective December 4, 2012.

FOR FURTHER INFORMATION CONTACT: Robbin Weyant, Director, Division of 
Select Agents and Toxins, Centers for Disease Control and Prevention, 
1600 Clifton Rd., MS A-46, Atlanta, GA 30333. Telephone: (404) 718-
2000.

SUPPLEMENTARY INFORMATION: In FR Doc. 2012-24389, published on October 
5, 2012 (77 FR 61084) appearing on pages 61086 and 61110, the following 
corrections are made: Preamble [Corrected]
    1. On page 61086, in the second column, second paragraph, beginning 
on the fourth line, ``According to available reports, Lujo virus (1) 
caused a fatal outbreak of hemorrhagic fever, (2) has a case fatality 
rate of 80 percent, (3) has been phylogenetically identified as an 
arenavirus, and (4) is related to those members of the Old World 
arenaviridae family (Junin, Machupo, Sabia, Guanarito, and Lassa) 
listed as HHS select agents that cause hemorrhagic fever and pose a 
significant risk to public health and safety (Ref 2)'' is corrected to 
read: ``According to available reports, Lujo virus (1) caused a fatal 
outbreak of hemorrhagic fever, (2) has a case fatality rate of 80 
percent, (3) has been phylogenetically identified as an arenavirus, and 
(4) is related to those members of the Arenaviridae family (Junin, 
Machupo, Sabia, Guanarito, and Lassa) listed as HHS select agents that 
cause hemorrhagic fever and pose a significant risk to public health 
and safety (Ref 2).''


Sec.  73.0  [Corrected]

    2. On page, 61110, in the second column, in Sec.  73.0 
(Applicability and related requirements), in paragraph one, ``All 
individuals and entities that possess SARS-CoV, Lujo virus, or Chapare 
virus must provide notice to CDC regarding their possession of SARS-
CoV, Lujo virus, or Chapare virus on or before November 5, 2012. 
Currently registered individuals and entities possessing SARS-CoV, Lujo 
virus, or Chapare virus must meet all the requirements of this part by 
December 4, 2012. All previously unregistered individuals and entities 
possessing SARS-CoV, Lujo virus, or Chapare virus must meet all of the 
requirements of this part by April 3, 2013 is corrected to read: ``All 
individuals and entities that possess SARS-CoV, Lujo virus, or Chapare 
virus must provide notice to CDC regarding their possession of SARS-
CoV, Lujo virus, or Chapare virus on or before December 4, 2012. 
Currently registered individuals and entities possessing SARS-CoV, Lujo 
virus, or Chapare virus must meet all the requirements of this part by 
December 4, 2012. All previously unregistered individuals and entities 
possessing SARS-CoV, Lujo virus, or Chapare virus must meet all of the 
requirements of this part by April 3, 2013.''

    Dated: November 21, 2012.
Kathleen Sebelius,
Secretary.
[FR Doc. 2012-28784 Filed 12-3-12; 8:45 am]
BILLING CODE 4163-18-P